Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer

Medical Oncology

Volumn 31, Issue 7, 2014, Pages

  Ye, Xiao Tian ^a   Guo, Ai Jun ^a   Yin, Peng Fei ^a   Cao, Xian Dong ^a   Chang, Jia Cong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Gastric cancer; NUAK1; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NUAK1 PROTEIN; UNCLASSIFIED DRUG; NUAK1 PROTEIN, HUMAN; PROTEIN KINASE; REPRESSOR PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STOMACH CANCER; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR INVASION; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH NEOPLASMS; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN KINASES; REPRESSOR PROTEINS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84902302550     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0061-1     Document Type: Article

References (25)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765-81. doi:10.1016/j.ejca.2009.12.014.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi:10.3322/caac.20107.
3. Bernal C, Aguayo F, Villarroel C, Vargas M, Diaz I, Ossandon FJ, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008;14(19):6264-9. doi:10.1158/1078-0432.CCR-07-4522.
4. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57(1):55-62. (Pubitemid 29308672)
5. Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, et al. Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene. 2004;23(42):7067-75. doi:10.1038/sj.onc.1207963. (Pubitemid 39319168)
6. Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M, et al. ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol. 2004;164(3):987-95. (Pubitemid 38235480)
7. Chen P, Li K, Liang Y, Li L, Zhu X. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion. Exp Lung Res. 2013;39(1):9-17. doi:10.3109/01902148.2012.744115.
8. Lu S, Niu N, Guo H, Tang J, Guo W, Liu Z, et al. ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome. Eur J Cancer. 2013;49(3):752-63. doi:10.1016/j.ejca.2012.09.018.
9. Kinoshita R, Iwadate M, Umeyama H, Taguchi YH. Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets. BMC Syst Biol. 2014;8(Suppl 1):S4. doi:10.1186/1752-0509-8-S1-S4.
10. Cui J, Yu Y, Lu GF, Liu C, Liu X, Xu YX, et al. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma. Tumour Biol. 2013;34(3):1913-8. doi:10.1007/s13277-013-0735-x.
11. Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML, Chang BW, et al. Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer. Med Oncol. 2013;30(2):595. doi:10.1007/s12032-013-0595-7.
12. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, et al. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer. 2008;123(8):1787-96. doi:10.1002/ijc.23746.
13. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12(1):17-20. (Pubitemid 43126077)
14. Hardie DG, Alessi DR. LKB1 and AMPK and the cancer-metabolism link: ten years after. BMC Biol. 2013;11:36. doi:10.1186/1741-7007-11-36.
15. Sun X, Gao L, Chien HY, Li WC, Zhao J. The regulation and function of the NUAK family. J Mol Endocrinol. 2013;51(2):R15-22. doi:10.1530/JME-13-0063.
16. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, et al. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem. 2003;278(1):48-53. doi:10.1074/jbc.M206025200. (Pubitemid 36043542)
17. Koh HJ, Toyoda T, Fujii N, Jung MM, Rathod A, Middelbeek RJ, et al. Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction- stimulated glucose transport in mouse skeletal muscle. Proc Natl Acad Sci USA. 2010;107(35):15541-6. doi:10.1073/pnas.1008131107.
18. Hou X, Liu JE, Liu W, Liu CY, Liu ZY, Sun ZY. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation. Oncogene. 2011;30(26):2933-42. doi:10.1038/onc.2011.19.
19. Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol. 2004;24(8):3526-35. (Pubitemid 38452091)
20. Humbert N, Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J. 2010;29(2):376-86. doi:10.1038/emboj.2009.342.
21. Liu L, Ulbrich J, Muller J, Wustefeld T, Aeberhard L, Kress TR, et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature. 2012;483(7391):608-12. doi:10.1038/nature10927.
22. Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer. 2000;3(4):177-86. (Pubitemid 32290724)
23. Chu D, Zhang Z, Li Y, Zheng J, Dong G, Wang W, et al. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer. 2011;129(4):887-95. doi:10.1002/ijc.25734.
24. Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29(3):1716-22. doi:10.1007/s12032-011-9990-0.
25. Chen W, Wang J, Li X, Li J, Zhou L, Qiu T, et al. Prognostic significance of BRCA1 expression in gastric cancer. Med Oncol. 2013;30(1):423. doi:10.1007/s12032-012-0423-5.